Abstract
Background
Age, gender and geographical regions are recognised factors in inequalities in prescribing for chronic diseases in the elderly.
Aim
To compare the health board regional distribution of chronic disease among the elderly and to examine variation in quality prescribing across age, gender and regions.
Methods
Population based study of prescribing for chronic disease using a national pharmacy claims database. All individuals aged 70 years and over (n=271,518) were eligible.
Results
Over 60% of the elderly in all regions received cardiovascular related medication. The South Eastern, North Western and Western Health Boards had below average prescribing for many chronic conditions. Logistic regression identified age, gender and regional variations in prescribing of preventative therapies for CVD and diabetes.
Conclusion
There is a high prevalence of prescribing for chronic conditions in the elderly in Ireland, and there is evidence of gender, age and residing health board inequalities in prescribing.
Similar content being viewed by others
References
Central statistics office. Population and migration estimates. www cso ie 2005.
EHEMU. Health Expectancy in Ireland. www hs le ac uk/reves/ehemutest 2005.
Lamy PP. Prescribing for thr elderly. In: Lamy PP, editor. The health status of the elderly. Littleton Mass: PSG Publicating CO, 1980. 113–117.
Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes.Eur J Clin Pharmacol 2000; 56(6–7):501–509.
Silwer L, Lundborg CS. Patterns of drug use during a 15 year period: data from a Swedish county, 1988–2002.Pharmacoepidemiol Drug Saf 2005; 14(11):813–820.
Bennett KE, Williams D, Feely J. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland.Ir Med J 2002; 95(6):169–172.
Bennett KE, Williams D, Feely J. Under-prescribing of cardiovascular therapies for diabetes in primary care.Eur J Clin Pharmacol 2003; 58(12):835–841.
Dornbrook-Lavender KA, Roth MT, Pieper JA. Secondary Prevention of Coronary Heart Disease in the Elderly.Ann Pharmacother 2003; 37(12):1867–1876.
Doyle F, De La HD, McGee H, Shelley E, Conroy R. Gender differences in the presentation and management of acute coronary syndromes: a national sample of 1365 admissions.Eur J Cardiovasc Prev Rehabil 2005; 12(4):376–379.
Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.Br J Clin Pharmacol 2003; 55(6):604–608.
Garavan R, Winder RMH. Health and Social Services for Older People (HeSSOP). national Council on Ageing and Older People, Dublin 2001; www.ncaop.ie.
Adamson J, Lawlor DA, Ebrahim S. Chronic diseases, locomotor activity limitation and social participation in older women: cross sectional survey of British Women’s Heart and Health Study.Age Ageing 2004; 33(3):293–298.
Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study.Eur J Clin Pharmacol 1998; 54(3):197–202.
Maio V, Yuen E, Rabinowitz C et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy.J Health Serv Res Policy 2005; 10(4):232–238.
Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data.J Clin Epidemiol 1992;45(2):197–203.
O’Hanlon A, Mc Gee H, Barker M et al. Health and social service for older people II (HeSSOPII). National Council on Ageing and Older People 2005; 91.
WHO. Anatomical therapeutics chemical (ATC) classification index with defined daily doses(DDDs). Geneva 2001.
Comhairle na nospideal. Consultant Staffing Jan 2005. www hse ie/comhairle na nospideal 2005.
National cancer registry Ireland. Cancer in Ireland 1994– 2001. www ncri ie 2005.
de Backer G., Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).Atherosclerosis 2004; 173(2):381–391.
American Society of Consultant Pharmacists. Drug Regimen Review Guidelines. www ascp com/public 2003.
HSE. GMS(P) B Financial & Statistical analysis of claims and payments 2004. Raven House, Finglas, Dublin 11; 2004.
Johnson Z, Hayes C, Dack P. The standardized prescribing ratio—a new method for comparing prescribing between GPs, controlling for patient age and sex.Pharmacoepidemiol Drug Saf 1997; 6(5):337–345.
DeWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG. Evolution of statin prescribing 1994–2001: a case of agism but not of sexism?Heart 2003; 89(4):417–421.
Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.Lancet 2002; 360(9346):1623–1630.
Bennett KE, Williams D, Feely J. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland.Ir Med J 2002; 95(6):169–172.
Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.Br J Clin Pharmacol 2003; 55(6):604–608.
Percudani M, Barbui C, Fortino I, Petrovich L. Antidepressant drug prescribing among elderly subjects: a population-based study.Int J Geriatr Psychiatry 2005; 20(2):113–118.
Roberts E, Norris P. Regional variation in anti-depressant dispensings in New Zealand:1993–1997.N Z Med J 2001; 114(125):27–30.
Usher C, Bennett K, Feely J. Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland.Pharmacoepidemiol Drug Saf 2005; 14(8):537–544.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naughton, C., Bennett, K. & Feely, J. Regional variation in prescribing for chronic conditions among an elderly population using a pharmacy claims database. Ir J Med Sci 175, 32–39 (2006). https://doi.org/10.1007/BF03169170
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03169170